APO RESEARCH · REPORT
Transcriptomics
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Product & engineering
Understand the product.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Selected research
Industry Research
Transcriptomics Industry Research Report 2026
Market perspective
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Report Scope
Read the full market overview
This report quantifies the global Transcriptomics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transcriptomics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transcriptomics Market by Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Transcriptomics Segment by Type
PCR
Microarray
Sequencing
Transcriptomics Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Transcriptomics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcriptomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcriptomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcriptomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transcriptomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PCR
- Microarray
- Sequencing
Applications
- Pharmaceutical and Biotechnology
- Academic Research and Government Institutes
- Hospitals and Diagnostic Centers
Companies covered
- Thermo Fisher Scientific
- Illumina
- QIAGEN (Exiqon)
- Agilent Technologies
- Roche
- GE Healthcare
- Bio-Rad Laboratories
- Fluidigm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Transcriptomics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 PCR
- 2.2.3 Microarray
- 2.2.4 Sequencing
- 2.3 Transcriptomics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology
- 2.3.3 Academic Research and Government Institutes
- 2.3.4 Hospitals and Diagnostic Centers
- 2.4 Assumptions and Limitations
3 Transcriptomics Breakdown Data by Type
- 3.1 Global Transcriptomics Historic Market Size by Type (2021-2026)
- 3.2 Global Transcriptomics Forecasted Market Size by Type (2027-2032)
4 Transcriptomics Breakdown Data by Application
- 4.1 Global Transcriptomics Historic Market Size by Application (2021-2026)
- 4.2 Global Transcriptomics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Transcriptomics Market Perspective (2021-2032)
- 5.2 Global Transcriptomics Growth Trends by Region
- 5.2.1 Global Transcriptomics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Transcriptomics Historic Market Size by Region (2021-2026)
- 5.2.3 Transcriptomics Forecasted Market Size by Region (2027-2032)
- 5.3 Transcriptomics Market Dynamics
- 5.3.1 Transcriptomics Industry Trends
- 5.3.2 Transcriptomics Market Drivers
- 5.3.3 Transcriptomics Market Challenges
- 5.3.4 Transcriptomics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Transcriptomics Players by Revenue
- 6.1.1 Global Top Transcriptomics Players by Revenue (2021-2026)
- 6.1.2 Global Transcriptomics Revenue Market Share by Players (2021-2026)
- 6.2 Global Transcriptomics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Transcriptomics Head Office and Area Served
- 6.4 Global Transcriptomics Players, Product Type & Application
- 6.5 Global Transcriptomics Manufacturers Established Date
- 6.6 Global Transcriptomics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Transcriptomics Market Size (2021-2032)
- 7.2 North America Transcriptomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Transcriptomics Market Size by Country (2021-2026)
- 7.4 North America Transcriptomics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Transcriptomics Market Size (2021-2032)
- 8.2 Europe Transcriptomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Transcriptomics Market Size by Country (2021-2026)
- 8.4 Europe Transcriptomics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Transcriptomics Market Size (2021-2032)
- 9.2 Asia-Pacific Transcriptomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Transcriptomics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Transcriptomics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Transcriptomics Market Size (2021-2032)
- 10.2 South America Transcriptomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Transcriptomics Market Size by Country (2021-2026)
- 10.4 South America Transcriptomics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Transcriptomics Market Size (2021-2032)
- 11.2 Middle East & Africa Transcriptomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Transcriptomics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Transcriptomics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Transcriptomics Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Transcriptomics Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Illumina
- 12.2.1 Illumina Company Information
- 12.2.2 Illumina Business Overview
- 12.2.3 Illumina Revenue in Transcriptomics Business (2021-2026)
- 12.2.4 Illumina Transcriptomics Product Portfolio
- 12.2.5 Illumina Recent Developments
- 12.3 QIAGEN (Exiqon)
- 12.3.1 QIAGEN (Exiqon) Company Information
- 12.3.2 QIAGEN (Exiqon) Business Overview
- 12.3.3 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2021-2026)
- 12.3.4 QIAGEN (Exiqon) Transcriptomics Product Portfolio
- 12.3.5 QIAGEN (Exiqon) Recent Developments
- 12.4 Agilent Technologies
- 12.4.1 Agilent Technologies Company Information
- 12.4.2 Agilent Technologies Business Overview
- 12.4.3 Agilent Technologies Revenue in Transcriptomics Business (2021-2026)
- 12.4.4 Agilent Technologies Transcriptomics Product Portfolio
- 12.4.5 Agilent Technologies Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Transcriptomics Business (2021-2026)
- 12.5.4 Roche Transcriptomics Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 GE Healthcare
- 12.6.1 GE Healthcare Company Information
- 12.6.2 GE Healthcare Business Overview
- 12.6.3 GE Healthcare Revenue in Transcriptomics Business (2021-2026)
- 12.6.4 GE Healthcare Transcriptomics Product Portfolio
- 12.6.5 GE Healthcare Recent Developments
- 12.7 Bio-Rad Laboratories
- 12.7.1 Bio-Rad Laboratories Company Information
- 12.7.2 Bio-Rad Laboratories Business Overview
- 12.7.3 Bio-Rad Laboratories Revenue in Transcriptomics Business (2021-2026)
- 12.7.4 Bio-Rad Laboratories Transcriptomics Product Portfolio
- 12.7.5 Bio-Rad Laboratories Recent Developments
- 12.8 Fluidigm
- 12.8.1 Fluidigm Company Information
- 12.8.2 Fluidigm Business Overview
- 12.8.3 Fluidigm Revenue in Transcriptomics Business (2021-2026)
- 12.8.4 Fluidigm Transcriptomics Product Portfolio
- 12.8.5 Fluidigm Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst